JP2022532706A5 - - Google Patents
Info
- Publication number
- JP2022532706A5 JP2022532706A5 JP2021566558A JP2021566558A JP2022532706A5 JP 2022532706 A5 JP2022532706 A5 JP 2022532706A5 JP 2021566558 A JP2021566558 A JP 2021566558A JP 2021566558 A JP2021566558 A JP 2021566558A JP 2022532706 A5 JP2022532706 A5 JP 2022532706A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- group
- pharmaceutically acceptable
- tautomer
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024180616A JP7844578B2 (ja) | 2019-05-08 | 2024-10-16 | THR-βの調節物質およびその使用方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962845252P | 2019-05-08 | 2019-05-08 | |
| US62/845,252 | 2019-05-08 | ||
| US201962944052P | 2019-12-05 | 2019-12-05 | |
| US62/944,052 | 2019-12-05 | ||
| US202063005661P | 2020-04-06 | 2020-04-06 | |
| US63/005,661 | 2020-04-06 | ||
| PCT/US2020/031904 WO2020227549A1 (en) | 2019-05-08 | 2020-05-07 | MODULATORS OF THR-β AND METHODS OF USE THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024180616A Division JP7844578B2 (ja) | 2019-05-08 | 2024-10-16 | THR-βの調節物質およびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022532706A JP2022532706A (ja) | 2022-07-19 |
| JP2022532706A5 true JP2022532706A5 (cg-RX-API-DMAC10.html) | 2023-05-12 |
| JP7574223B2 JP7574223B2 (ja) | 2024-10-28 |
Family
ID=70919081
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566558A Active JP7574223B2 (ja) | 2019-05-08 | 2020-05-07 | THR-βの調節物質およびその使用方法 |
| JP2024180616A Active JP7844578B2 (ja) | 2019-05-08 | 2024-10-16 | THR-βの調節物質およびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024180616A Active JP7844578B2 (ja) | 2019-05-08 | 2024-10-16 | THR-βの調節物質およびその使用方法 |
Country Status (32)
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121081472A (zh) | 2018-12-13 | 2025-12-09 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| WO2020227549A1 (en) | 2019-05-08 | 2020-11-12 | Aligos Therapeutics, Inc. | MODULATORS OF THR-β AND METHODS OF USE THEREOF |
| CA3154488A1 (en) * | 2019-08-23 | 2021-03-04 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| CA3154391A1 (en) | 2019-09-12 | 2021-03-18 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| CA3158379A1 (en) * | 2019-11-26 | 2021-06-03 | Hejun Lv | 1,2,4-triazine-3,5-dione compound, preparation method therefor, and application thereof |
| WO2021129465A1 (zh) * | 2019-12-26 | 2021-07-01 | 苏州科睿思制药有限公司 | 一种Resmetirom晶型及其制备方法和用途 |
| CN113278013B (zh) * | 2020-02-20 | 2022-09-23 | 昆药集团股份有限公司 | 2,6-二取代的1,2,4-三嗪-3,5-二酮化合物及其制备方法和应用 |
| WO2021244582A1 (zh) * | 2020-06-02 | 2021-12-09 | 成都康弘药业集团股份有限公司 | 新型甲状腺激素β受体激动剂 |
| EP4167986A4 (en) | 2020-06-17 | 2024-11-20 | Autobahn Therapeutics, Inc. | THYROMIMETICS |
| EP4168384A4 (en) | 2020-06-17 | 2024-07-10 | Autobahn Therapeutics, Inc. | THYROMIMETICS |
| KR20230066408A (ko) * | 2020-09-10 | 2023-05-15 | 크리스탈 파마슈티컬 (쑤저우) 씨오., 엘티디. | 레스메티롬의 결정형, 이의 제조 방법 및 이의 용도 |
| WO2022053028A1 (zh) * | 2020-09-10 | 2022-03-17 | 南京明德新药研发有限公司 | 1,2,4-三嗪-3,5(2h,4h)-二酮类化合物及其应用 |
| EP4215524A4 (en) * | 2020-09-17 | 2024-10-02 | Sunshine Lake Pharma Co., Ltd. | COMPOUND AS A THYROID HORMONE BETA RECEPTOR AGONIST AND USES OF THE COMPOUND |
| US11793815B2 (en) | 2020-11-06 | 2023-10-24 | Aligos Therapeutics, Inc. | Oxindoles and methods of use thereof |
| AU2021376281A1 (en) | 2020-11-06 | 2023-06-15 | Aligos Therapeutics, Inc. | Pyridazinone derivatives as thyroid receptor agonists and uses thereof |
| CN114591300A (zh) * | 2020-12-04 | 2022-06-07 | 南京圣和药业股份有限公司 | 作为THRβ激动剂的杂环化合物及其应用 |
| CN112645936B (zh) * | 2020-12-17 | 2022-03-01 | 山东第一医科大学(山东省医学科学院) | 取代的哒嗪酮类化合物及其用途 |
| CN114685450B (zh) * | 2020-12-30 | 2026-06-16 | 昆药集团股份有限公司 | 2-吡啶酮类衍生物及其制备方法和在医药上的应用 |
| CN114907327A (zh) * | 2021-02-10 | 2022-08-16 | 杭州领业医药科技有限公司 | Resmetirom的晶型及其制备方法和用途 |
| JP2024510935A (ja) * | 2021-03-03 | 2024-03-12 | ターンズ・ファーマシューティカルズ・インコーポレイテッド | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
| WO2022184177A1 (zh) * | 2021-03-04 | 2022-09-09 | 甫康(上海)健康科技有限责任公司 | 一种芳香化合物、其制备方法及其应用 |
| CN115073429A (zh) * | 2021-03-15 | 2022-09-20 | 昆药集团股份有限公司 | 一种1,2,4-三嗪-3,5-二酮类化合物的盐型、晶型及其制备方法 |
| TW202313615A (zh) * | 2021-05-21 | 2023-04-01 | 大陸商深圳微芯生物科技股份有限公司 | 一種雜環化合物及其應用 |
| WO2023023474A1 (en) * | 2021-08-16 | 2023-02-23 | Senya Pharmaceuticals, Inc. | Tr-beta modulators, pharmaceutical compositions, and therapeutic applications |
| US20250243491A1 (en) | 2021-09-01 | 2025-07-31 | Aligos Therapeutics, Inc. | Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof |
| CA3230382A1 (en) | 2021-09-08 | 2023-03-16 | Aligos Therapeutics, Inc. | Modified short interfering nucleic acid (sina) molecules and uses thereof |
| TWI910297B (zh) * | 2021-12-24 | 2026-01-01 | 大陸商廣東東陽光藥業股份有限公司 | 一種作為甲狀腺激素β受體激動劑的化合物及其用途 |
| CN116354934A (zh) * | 2021-12-28 | 2023-06-30 | 中国科学院上海药物研究所 | 一类喹啉类化合物及其制备方法、药物组合物和用途 |
| CN119137113A (zh) * | 2022-02-10 | 2024-12-13 | 马德里加尔制药公司 | THRβ类似物及其用途 |
| CN115650928B (zh) * | 2022-12-28 | 2023-03-31 | 凯思凯旭(上海)医药科技有限公司 | 一种多环类甲状腺激素β受体激动剂及其用途 |
| WO2024182446A2 (en) | 2023-02-28 | 2024-09-06 | Aligos Therapeutics, Inc. | Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof |
| US20240352464A1 (en) | 2023-03-07 | 2024-10-24 | Aligos Therapeutics, Inc. | Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof |
| PE20252787A1 (es) | 2023-04-07 | 2025-12-22 | Terns Pharmaceuticals Inc | Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica |
| CN121358734A (zh) * | 2023-06-19 | 2026-01-16 | 西威埃医药技术(上海)有限公司 | THR-β受体激动剂、其制备方法和其使用方法 |
| WO2025011259A1 (zh) * | 2023-07-07 | 2025-01-16 | 苏州科睿思制药有限公司 | 瑞司美替罗的晶型及其制备方法和用途 |
| CN117327057B (zh) * | 2023-08-30 | 2026-03-03 | 南京雷正医药科技有限公司 | 一类作为甲状腺激素受体激动剂的三嗪二酮类化合物及其合成、用途 |
| WO2025137568A1 (en) * | 2023-12-21 | 2025-06-26 | Aligos Therapeutics, Inc. | Modulators of thr-beta and methods of use thereof |
| TW202604525A (zh) | 2024-05-03 | 2026-02-01 | 美商艾利格斯醫療公司 | 製備THR-β調節劑之方法 |
| WO2025252147A1 (zh) * | 2024-06-07 | 2025-12-11 | 珠海联邦制药股份有限公司 | 一种甲状腺激素β受体激动剂的化合物及其应用 |
| WO2026050911A1 (zh) * | 2024-09-04 | 2026-03-12 | 西威埃医药技术(上海)有限公司 | 一种TR-β选择性激动剂的晶型、制备方法和应用 |
| WO2026067791A1 (en) | 2024-09-30 | 2026-04-02 | Ascletis Pharma (China) Co., Limited | 2-phenyl-1,2,4-triazine-3,5(2h,4h)-dione derivatives as thr-beta agonist or modulators for the treatment of obesity |
| US20260102403A1 (en) | 2024-10-11 | 2026-04-16 | Aligos Therapeutics, Inc. | Oral formulations of thr-beta agonist |
| WO2026092583A1 (en) | 2024-10-30 | 2026-05-07 | Ascletis Pharma (China) Co., Limited | Thr-beta modulators, alone or in combination with glp-1r\gipr\gcgr modulators for the treatment of metabolic diseases and alopecia areata diseases |
| CN120923503A (zh) * | 2025-10-10 | 2025-11-11 | 吉斯凯(苏州)制药有限公司 | 具有杂环结构的化合物、THRβ受体激动剂及用途 |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
| US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
| DE60020786T2 (de) | 1999-09-30 | 2006-03-23 | Pfizer Products Inc., Groton | 6-Azauracilderivate als Liganden der Thyroidrezeptoren |
| GB0015205D0 (en) | 2000-06-21 | 2000-08-09 | Karobio Ab | Bioisosteric thyroid receptor ligands and method |
| ES2267945T3 (es) | 2001-05-31 | 2007-03-16 | Pfizer Products Inc. | Uso medico de compuestos tiromimeticos para tratar la perdida del cabello y composiciones. |
| CA2473162A1 (en) * | 2002-01-30 | 2003-08-07 | Kissei Pharmaceutical Co., Ltd. | Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| IL166241A0 (en) | 2002-07-29 | 2006-01-15 | Rigel Pharmaceuticals Inc | Method of treating or preventing autoimmune diseases with 2,4-pyrimidinedinediamine compounds |
| WO2004047827A1 (en) | 2002-11-25 | 2004-06-10 | Pfizer Products Inc. | Method for promoting nail growth using thyromimetic compounds |
| ATE480524T1 (de) | 2005-07-21 | 2010-09-15 | Hoffmann La Roche | Pyridazinonderivate als schilddrüsenhormon- rezeptoragonisten |
| JP2009521448A (ja) * | 2005-12-21 | 2009-06-04 | シェーリング コーポレイション | ヒスタミンh3アンタゴニストとして有用なフェノキシピペリジンおよびそのアナログ |
| CN101506158A (zh) * | 2006-06-28 | 2009-08-12 | 株式会社三和化学研究所 | 新6-5系二环式杂环衍生物及其医药用途 |
| WO2008104752A1 (en) * | 2007-02-26 | 2008-09-04 | Astrazeneca Ab | Dihydropyridones as elastase inhibitors |
| US8076334B2 (en) * | 2007-09-20 | 2011-12-13 | Hoffmann-La Roche Inc. | Prodrugs of thyroid hormone analogs |
| KR101396606B1 (ko) | 2009-04-20 | 2014-05-16 | 미쓰비시 타나베 파마 코퍼레이션 | 신규 갑상선 호르몬 β 수용체 작동약 |
| JP5847533B2 (ja) | 2010-10-19 | 2016-01-27 | 田辺三菱製薬株式会社 | 新規甲状腺ホルモンβ受容体作動薬 |
| DK2695611T3 (en) | 2012-08-06 | 2015-01-05 | Wolff August Gmbh & Co Kg Arzneimittel Dr | Eprotirome for use in the prevention and / or treatment of hair disorders and their compositions |
| ES2795450T3 (es) | 2012-09-17 | 2020-11-23 | Madrigal Pharmaceuticals Inc | Procedimiento para sintetizar análogos de hormonas tiroideas y polimorfos de los mismos |
| EP3019196B1 (en) | 2013-07-09 | 2018-06-06 | Bristol-Myers Squibb Company | Combinations of hepatitis c virus inhibitors |
| US10303567B2 (en) | 2013-08-15 | 2019-05-28 | Entit Software Llc | Managing database nodes |
| GB201318793D0 (en) | 2013-10-24 | 2013-12-11 | Plaquetec Ltd | Vascular Biomarkers |
| MX2017008844A (es) | 2015-01-09 | 2018-03-14 | Gilead Apollo Llc | Terapia de combinacion con inhibidor de acetil-coa carboxilasa (acc) para el tratamiento de enfermedad de higado graso no alcoholico. |
| KR102444366B1 (ko) | 2016-06-03 | 2022-09-19 | 케모센트릭스, 인크. | 간 섬유화 치료 방법 |
| MX394463B (es) | 2016-10-18 | 2025-03-19 | Madrigal Pharmaceuticals Inc | Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta. |
| SG11201907673YA (en) | 2017-03-13 | 2019-09-27 | Genfit | Pharmaceutical compositions for combination therapy |
| CA3058542A1 (en) | 2017-04-18 | 2018-10-25 | Genfit | Combination comprising a ppar agonist such as elafibranor and an acetyl-coa carboxylase (acc) inhibitor |
| US10857144B2 (en) | 2017-05-16 | 2020-12-08 | Bow River LLC | Methods of treatment |
| US11808772B2 (en) | 2017-07-19 | 2023-11-07 | Bio-Rad Europe Gmbh | Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status |
| WO2019099457A1 (en) | 2017-11-14 | 2019-05-23 | Quixgen, Inc. | Benzodioxinone compounds |
| IL308604B2 (en) | 2017-12-06 | 2025-08-01 | Basf As | Fatty acid derivatives for treating non-alcoholic steatohepatitis |
| CN109574995B (zh) | 2018-01-23 | 2020-07-24 | 深圳市塔吉瑞生物医药有限公司 | 取代的哒嗪酮化合物 |
| EP3765059A4 (en) | 2018-03-12 | 2022-01-12 | Yale University | METHODS OF TREATMENT OR PREVENTION OF ACUTE RESPIRATORY SYNDROME |
| WO2019213611A1 (en) | 2018-05-04 | 2019-11-07 | Cirius Therapeutics, Inc. | Thiazolidinedione analogs for the treatment of nafld and metabolic diseases |
| CN108727344A (zh) | 2018-05-14 | 2018-11-02 | 嘉兴特科罗生物科技有限公司 | 一种化合物及其合成方法和应用 |
| ES3029158T3 (en) | 2018-06-12 | 2025-06-23 | Xizang Haisco Pharmaceutical Co Ltd | Thyroid hormone receptor agonists and uses thereof |
| EP3806832A1 (en) | 2018-06-14 | 2021-04-21 | Alma Mater Studiorum - Università di Bologna | Electrospun fibers for a local release of an anti-inflammatory drug and a promyelinating drug |
| US20210292304A1 (en) | 2018-06-22 | 2021-09-23 | Hinova Pharmaceuticals Inc. | Deuterated mgl-3196 compound and use thereof |
| TW202615431A (zh) | 2018-07-02 | 2026-04-16 | 美商瑪德瑞高製藥公司 | 2-(3,5-二氯-4-((5-異丙基-6-側氧基-1,6-二氫噠嗪-3-基)氧)苯基)-3,5-二側氧基-2,3,4,5-四氫-1,2,4-三嗪-6-腈之固體型式 |
| TWI825144B (zh) | 2018-08-10 | 2023-12-11 | 美商思達利醫藥公司 | 第二型轉麩醯胺酸酶(tg2)抑制劑 |
| WO2020041741A1 (en) | 2018-08-24 | 2020-02-27 | Terns, Inc. | Thyroid hormone receptor beta agonist compounds |
| CN119552152A (zh) * | 2018-10-12 | 2025-03-04 | 益方生物科技(上海)股份有限公司 | 甲状腺激素受体激动剂 |
| TWI884745B (zh) | 2018-10-12 | 2025-05-21 | 美商拓臻股份有限公司 | 甲狀腺素受體β促效劑化合物 |
| CN121081472A (zh) | 2018-12-13 | 2025-12-09 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| CN119431265A (zh) | 2019-02-21 | 2025-02-14 | 南京瑞捷医药科技有限公司 | 一种作为甲状腺激素受体激动剂的化合物 |
| WO2020227549A1 (en) * | 2019-05-08 | 2020-11-12 | Aligos Therapeutics, Inc. | MODULATORS OF THR-β AND METHODS OF USE THEREOF |
| WO2020228577A1 (zh) | 2019-05-10 | 2020-11-19 | 深圳微芯生物科技股份有限公司 | 一种哒嗪酮衍生物及其应用 |
| IT201900006923A1 (it) | 2019-05-16 | 2020-11-16 | International Soc For Drug Development S R L | Nuovi tiromimetici con uno scaffold bifenilmetano e loro uso |
| WO2020239076A1 (zh) | 2019-05-29 | 2020-12-03 | 南京明德新药研发有限公司 | 作为甲状腺素受体-β激动剂的哒嗪酮类衍生物及其应用 |
| CN112300133B (zh) | 2019-07-31 | 2024-07-30 | 深圳微芯生物科技股份有限公司 | 一种杂环化合物及其应用 |
| EP4019524A4 (en) | 2019-08-19 | 2024-01-03 | Hepagene Therapeutics (HK) Limited | HETEROCYCLIC THR-BETA RECEPTOR AGONIST COMPOUND, PREPARATION METHOD AND USE THEREOF |
| CN112409340B (zh) | 2019-08-21 | 2022-03-18 | 海创药业股份有限公司 | 卤素取代的苯醚类化合物及其用途 |
| CA3154488A1 (en) | 2019-08-23 | 2021-03-04 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| CN112442013B (zh) | 2019-09-04 | 2022-07-26 | 广东东阳光药业有限公司 | 一种作为甲状腺激素β受体激动剂的化合物及其用途 |
| CA3154391A1 (en) | 2019-09-12 | 2021-03-18 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| WO2021057791A1 (zh) | 2019-09-24 | 2021-04-01 | 广东东阳光药业有限公司 | 一种作为甲状腺激素Beta受体激动剂的化合物及其用途 |
| CN112707892A (zh) | 2019-10-24 | 2021-04-27 | 苏州泽璟生物制药股份有限公司 | 哒嗪酮或哒嗪类化合物及其衍生物和药物组合物 |
| CA3158379A1 (en) | 2019-11-26 | 2021-06-03 | Hejun Lv | 1,2,4-triazine-3,5-dione compound, preparation method therefor, and application thereof |
| MX2022008626A (es) | 2020-01-13 | 2022-08-22 | Eccogene Shanghai Co Ltd | Triazinonas sustituidas como agonistas del receptor de la hormona tiroidea. |
| MX2022012469A (es) | 2020-04-06 | 2022-10-27 | Basf Se | Compuestos de imidazo-pirimidona como plaguicidas. |
-
2020
- 2020-05-07 WO PCT/US2020/031904 patent/WO2020227549A1/en not_active Ceased
- 2020-05-07 DK DK20729390.3T patent/DK3965884T3/da active
- 2020-05-07 CN CN202610211424.5A patent/CN122036699A/zh active Pending
- 2020-05-07 ES ES20729390T patent/ES3020290T3/es active Active
- 2020-05-07 CA CA3139101A patent/CA3139101A1/en active Pending
- 2020-05-07 AU AU2020267576A patent/AU2020267576B2/en active Active
- 2020-05-07 CN CN202080047744.2A patent/CN114096531B/zh active Active
- 2020-05-07 JP JP2021566558A patent/JP7574223B2/ja active Active
- 2020-05-07 SI SI202030599T patent/SI3965884T1/sl unknown
- 2020-05-07 FI FIEP20729390.3T patent/FI3965884T3/fi active
- 2020-05-07 PH PH1/2021/552782A patent/PH12021552782A1/en unknown
- 2020-05-07 MY MYPI2021006587A patent/MY210357A/en unknown
- 2020-05-07 LT LTEPPCT/US2020/031904T patent/LT3965884T/lt unknown
- 2020-05-07 PL PL20729390.3T patent/PL3965884T3/pl unknown
- 2020-05-07 RS RS20250336A patent/RS66686B1/sr unknown
- 2020-05-07 MA MA55890A patent/MA55890B1/fr unknown
- 2020-05-07 EP EP24213541.6A patent/EP4523692A3/en active Pending
- 2020-05-07 KR KR1020217039735A patent/KR102968107B1/ko active Active
- 2020-05-07 PE PE2021001847A patent/PE20220255A1/es unknown
- 2020-05-07 GE GEAP202015821A patent/GEP20247637B/en unknown
- 2020-05-07 GE GEAP202415821A patent/GEAP202415821A/en unknown
- 2020-05-07 BR BR112021021718A patent/BR112021021718A2/pt unknown
- 2020-05-07 MD MDE20220295T patent/MD3965884T2/ro unknown
- 2020-05-07 MX MX2021013472A patent/MX2021013472A/es unknown
- 2020-05-07 SG SG11202111552YA patent/SG11202111552YA/en unknown
- 2020-05-07 HR HRP20250384TT patent/HRP20250384T1/hr unknown
- 2020-05-07 HU HUE20729390A patent/HUE070650T2/hu unknown
- 2020-05-07 US US16/869,211 patent/US11091467B2/en active Active
- 2020-05-07 PT PT207293903T patent/PT3965884T/pt unknown
- 2020-05-07 EP EP20729390.3A patent/EP3965884B1/en active Active
- 2020-05-08 TW TW109115446A patent/TWI855068B/zh active
-
2021
- 2021-05-25 US US17/330,232 patent/US12180192B2/en active Active
- 2021-10-31 IL IL287720A patent/IL287720A/en unknown
- 2021-11-03 CL CL2021002883A patent/CL2021002883A1/es unknown
- 2021-11-23 CO CONC2021/0015698A patent/CO2021015698A2/es unknown
-
2024
- 2024-10-16 JP JP2024180616A patent/JP7844578B2/ja active Active
- 2024-11-28 ZA ZA2024/09114A patent/ZA202409114B/en unknown
- 2024-12-30 US US19/004,657 patent/US20250304561A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113507931B (zh) | 调节短链脱氢酶活性的组合物和方法 | |
| JP7835895B2 (ja) | Parp1を選択的に阻害するフルオロキノキサリノン誘導体 | |
| WO2020094104A1 (zh) | 一类含氮稠杂环类shp2抑制剂化合物、制备方法和用途 | |
| JP2021531256A (ja) | NaV1.8を阻害するピリダジン化合物 | |
| JP2021527638A (ja) | B型肝炎カプシドアセンブリモジュレーター | |
| AU2019233207B2 (en) | Heteroaryl compounds as kinase inhibitor | |
| ES3062921T3 (en) | Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation method | |
| BRPI0710231A2 (pt) | composto, composição farmacêutica, e, intermediário para a preparação de um composto | |
| EA020138B1 (ru) | Арилпиридины в качестве ингибиторов альдостеронсинтазы | |
| FR2943669A1 (fr) | Derives de nicotinamide,leur preparation et leur application en therapeutique | |
| CN104011019B (zh) | 吡咯衍生物 | |
| JP2005119987A (ja) | アシルスルホンアミド誘導体 | |
| TW202214626A (zh) | 雌激素受體調節劑化合物及其用途 | |
| JP2018510131A (ja) | Rorc2のスルホンアミド置換インドールモジュレーターおよびその使用方法 | |
| TW202415647A (zh) | 抑制Bcl-2或Bcl-xL的化合物及其在醫藥上的應用 | |
| IL293497A (en) | Compounds for the activity module of fxr and its uses | |
| JP2020519697A (ja) | インドリジン誘導体及びその医学的応用 | |
| JP2014525418A (ja) | タンパク質キナーゼ阻害活性を有する4−置換−(3−置換−1h−ピラゾール−5−アミノ)−ピリミジン誘導体及びその使用 | |
| CA2901766A1 (en) | N-(2-cyano heterocyclyl)pyrazolo pyridones as janus kinase inhibitors | |
| MX2007015705A (es) | Derivados biciclicos como inhibidores de la cinasa p38. | |
| JP2020520388A (ja) | Ldha活性阻害剤 | |
| CN119110795A (zh) | 用于治疗与lpa受体活性相关的病症的化合物和组合物 | |
| JP2021519825A (ja) | 輸送体の調節薬としての二環式エノンカルボキシラートとその使用 | |
| WO2025098417A1 (zh) | 磺酰胺类化合物及其应用 | |
| WO2025162280A1 (zh) | 吡唑羧酸衍生物及其在医药上的应用 |